跳至主要内容
临床试验/JPRN-jRCTs041180135
JPRN-jRCTs041180135进行中(未招募)2 期

Effect of 5-aminolevulinic acid against patients with early phase Alzheimer disease -Exploratory randomized controlled trial

Matsukawa Noriyuki0 个研究点目标入组 40 人开始时间: 2019年3月26日最近更新:
适应症

试验速览

阶段
2 期
状态
进行中(未招募)
发起方
入组人数
40

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
>= 50age old 至 <= 90age old(—)
性别
All

入选标准

  • 1) Clinical diagnose as Alzheimer disease following NINCDS-ADRDA criteria
  • a) memory disorder and other connitive dysfunction
  • b) progressive impairment of cognitive function
  • 2) MMSE 20-24
  • 3) FAST stage 3-4
  • 4) rule out of conscious disorder and/or any psychiatric disease
  • 5) 50-90 years-old
  • 6) written document of informed consent

排除标准

  • 1) patients with psychiatric symptom affecting cognitive estimation
  • 2) patients with hearing disorder affecting cognitive estimation
  • 3) patients with physiological disorder affecting cognitive estimation
  • 4) patients under impossible phrmaceutical manegement
  • 5) patients under impossible MRI image of head
  • 6) patients judged as unsuitable by madical doctor

研究者

发起方
Matsukawa Noriyuki

相似试验